Table 5.
No use | Baseline multivitamin use |
P value | |
---|---|---|---|
Through the intervention period (10 years) | |||
N | 13,828 | 8577 | |
SBP | |||
Age-adjusted mean (SD) | 5.19 (0.56) | 5.17 (0.57) | 0.91 |
+ Lifestyle, clinical, dietary factorsa | 5.52 (0.58) | 5.56 (0.59) | 0.85 |
DBP | |||
Age-adjusted mean (SD) | 0.24 (0.42) | 0.24 (0.43) | 0.99 |
+ Lifestyle, clinical, dietary factors | 0.66 (0.44) | 0.62 (0.44) | 0.76 |
Through the observational follow-up period (18 years) |
|||
N | 5715 | 3487 | |
SBP | |||
Age-adjusted mean (SD) | 5.33 (1.06) | 5.19 (1.07) | 0.63 |
+ Lifestyle, clinical, dietary factors | 5.56 (1.08) | 5.34 (1.09) | 0.42 |
DBP | |||
Age-adjusted mean (SD) | −1.10 (0.84) | −0.87 (0.85) | 0.30 |
+ Lifestyle, clinical, dietary factors | −1.00 (0.85) | −0.91 (0.86) | 0.69 |
SD, standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure
Additionally adjusted for body mass index, smoking, physical activity, postmenopausal status, randomized treatment assignment, diabetes history, hypercholesterolemia history, alcohol consumption, intakes of fruits and vegetables, and whole grains.